This content is from: Patents

Bayer: urgent need for patent term extension in China

Jörg Thomaier, head of IP at Bayer, explains why PTE will help the pharma industry and what an ideal patent linkage system looks like

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial